The Planntz blog100 pieces

Notes on balance, hemp & the everyday ritual.

Plain-language guides, wellness routines and stories from behind the brand. No noise, just what helps you feel like yourself.

CBD Gum: What Chewing Delivers and What One Trial FoundFeatured
Quality & Buying

CBD Gum: What Chewing Delivers and What One Trial Found

CBD gum has one placebo-controlled trial, no published blood study and a speed claim borrowed from caffeine gum. Here is what chewing delivers, what the trial found, how to read the label and two safety points most pages skip.

Planntz Editorial Team·16 min read
Read the guide
Latest news

From the newsroom

Cochrane Reviewed Medical Cannabis for Insomnia: What It Found, and What It Could Not TestCochrane Database of Systematic Reviews (CD016216, 2026)01

Cochrane Reviewed Medical Cannabis for Insomnia: What It Found, and What It Could Not Test

On October 13, 2026, Cochrane pooled 9 randomized trials in 537 adults with insomnia. Medical cannabis may have little to no clinically meaningful effect on sleep, on very low-certainty evidence, with more adverse events (low certainty).

Oct 13, 2026·15 min read
DEA Proposes a New 7-OH Threshold and Withdraws the July One: What Changes, and WhenU.S. Drug Enforcement Administration (Federal Register 2026-20943)02

DEA Proposes a New 7-OH Threshold and Withdraws the July One: What Changes, and When

On October 9, 2026, DEA filed a notice of intent proposing a new 7-OH threshold: more than 1 mg per gram or per mL, or a mitragynine ratio under 100. DEA says it is withdrawing the July 6 version. No order can issue before November 13, 2026.

Oct 10, 2026·16 min read
FDA Drops Premarket Review for Federal Drug-Test Devices: What Changed, and What Did NotU.S. Food and Drug Administration (Federal Register 2026-20448)03

FDA Drops Premarket Review for Federal Drug-Test Devices: What Changed, and What Did Not

On October 6, 2026, FDA let drug-test systems in 14 categories, including cannabinoid tests, skip 510(k) review for federal programs. Saliva testing for DOT jobs is still not here: HHS's latest list shows no certified oral-fluid lab.

Oct 6, 2026·14 min read
WADA's 2027 Cannabinoid Rule: CBD Is Still Allowed, and the Blanket Clause Is GoneWorld Anti-Doping Agency04

WADA's 2027 Cannabinoid Rule: CBD Is Still Allowed, and the Blanket Clause Is Gone

WADA published its 2027 Prohibited List on September 21, 2026. CBD is still not prohibited and THC still is, in-competition. The sentence that banned all natural and synthetic cannabinoids is gone, and WADA has not said what that means for CBG, CBN or THCV.

Sep 23, 2026·18 min read
An Appeals Court Left Medical Marijuana in Schedule III. It Did Not Decide the CaseU.S. Court of Appeals, D.C. Circuit05

An Appeals Court Left Medical Marijuana in Schedule III. It Did Not Decide the Case

On September 9, 2026 the D.C. Circuit denied a stay of the April order placing state-licensed medical marijuana in Schedule III. The challenges are still pending, broader rescheduling is still a proposal, and the rule says it does not affect hemp.

Sep 14, 2026·17 min read
A Randomized Trial Gave 18 Adults 12.5 mg of THC, With and Without CBD. Both Oils Raised Heart Rate.Br J Clin Pharmacol06

A Randomized Trial Gave 18 Adults 12.5 mg of THC, With and Without CBD. Both Oils Raised Heart Rate.

A randomized, double-blind crossover trial published on August 27, 2026 gave 18 healthy adults 12.5 mg of THC, with and without 12.5 mg of CBD, then made them breathe against a resistance. Both oils raised heart rate. Here is what the record supports and what it does not.

Sep 12, 2026·20 min read
A Trial Tested CBD Ads. The Control Group Is the StoryClinicalTrials.gov07

A Trial Tested CBD Ads. The Control Group Is the Story

On August 28, 2026 results were posted for a randomized trial that put 460 shoppers through a simulated mini mart. In the room with no CBD advertising at all, shoppers endorsed 5.6 of 12 listed benefits and 163 of 230 bought a CBD-branded product anyway.

Sep 7, 2026·23 min read
The FDA GRAS Proposal: How a New Ingredient Reaches a Shelf, and Why It Names Delta-8 THCFederal Register08

The FDA GRAS Proposal: How a New Ingredient Reaches a Shelf, and Why It Names Delta-8 THC

On August 11, 2026 FDA proposed making GRAS notification mandatory, and it names Delta-8 THC foods among its five examples. It is a proposal: comments close December 9, 2026, two days before the federal hemp-definition change takes effect.

Sep 6, 2026·25 min read
DEA Scheduled Three Kratom Analogs on August 26. It Did Not Schedule 7-OHFederal Register09

DEA Scheduled Three Kratom Analogs on August 26. It Did Not Schedule 7-OH

On August 26, 2026 DEA placed three kratom-derived analogs in Schedule I by temporary order: mitragynine pseudoindoxyl, MGM-15 and MGM-16. It did not schedule 7-hydroxymitragynine and it did not name kratom leaf. The HHS comment window closes September 10, 2026.

Sep 4, 2026·25 min read
Congress Moved the Hemp Deadline to December 11, and Left One Piece on November 12The White House010

Congress Moved the Hemp Deadline to December 11, and Left One Piece on November 12

On September 2, 2026 a single-sentence section inside H.R. 6500 split the 2026 hemp deadline in two. Most of the new definition now arrives on December 11, 2026. One exclusion still arrives on November 12, and it is the one whose official list does not exist.

Sep 3, 2026·23 min read

Latest stories

Guides, rituals & field notes
Stay in the loop

Never miss a drop.

New articles, wellness notes and the occasional founder letter, straight to your inbox.

By subscribing you agree to our privacy policy. Unsubscribe anytime.